[Preventive effect of aprepitant, an oral NK₁ receptor antagonist, on acute and delayed chemotherapy-induced nausea and vomiting for colorectal cancer].Kazuaki Fukazawa, Ayano Nakazawa, +7 authors Yasuo HosouchiGan to kagaku ryoho. Cancer & chemotherapy2011A standard therapeutic regimen of a 5-HT₃ receptor antagonist antiemetic agent+dexamethasone was administered as antiemetic therapy for 29 patients who received chemotherapy for colorectal cancer in… (More)